Eylea and Klonopin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eylea (aflibercept) and Klonopin (clonazepam). Common drug interactions include injection site haemorrhage among females and eye irritation among males.

The phase IV clinical study analyzes what interactions people have when they take Eylea and Klonopin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

What is Klonopin?

Klonopin has active ingredients of clonazepam. It is often used in stress and anxiety. eHealthMe is studying from 65,112 Klonopin users. Check the latest studies of Klonopin.



On Jul, 18, 2026

16 people who take Eylea and Klonopin together, and have interactions are studied.

Eylea and Klonopin drug interactions.

What are the common drug interactions of Eylea and Klonopin, by gender? *:

female:

  1. Injection site haemorrhage (bleeding from injection site)
  2. Injection site pain
  3. Nystagmus (a condition of involuntary eye movement)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Visual impairment
  6. Vitreous floaters (spots before the eyes)
  7. Blindness unilateral
  8. Drug ineffective
  9. Eye disorder

male:

  1. Eye irritation
  2. Ocular hyperaemia (an abnormally large amount of blood in eye)
  3. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiac disorder
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Pneumonia

What are the common drug interactions of Eylea and Klonopin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Blindness unilateral
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Eye disorder
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the existing conditions these people have? *

  1. Age-Related Macular Degeneration: 2 people, 12.50%
  2. Renal Disorder (kidney disease): 2 people, 12.50%
  3. Prostatic Disorder: 2 people, 12.50%
  4. Parkinson's Disease: 2 people, 12.50%
  5. Blood Cholesterol Decreased: 2 people, 12.50%
  6. Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 2 people, 12.50%
  7. Insomnia (sleeplessness): 2 people, 12.50%
  8. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 6.25%
  9. Back Pain: 1 person, 6.25%
  10. Cardiac Failure Congestive: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Eylea and Klonopin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eylea and Klonopin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eylea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klonopin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eylea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klonopin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aflibercept and clonazepam (the active ingredients of Eylea and Klonopin, respectively), and Eylea and Klonopin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: